Can a hormone shot help fight advanced breast cancer? new trial begins
Disease control
Recruiting now
This Phase 1 trial is testing ZOLADEX (goserelin), a hormone-blocking implant, in 88 premenopausal women with HR+/HER2- advanced breast cancer. The goal is to see if it can temporarily shut down ovarian function, which may help control the cancer. Participants receive two injecti…
Phase: PHASE1 • Sponsor: TerSera Therapeutics LLC • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC